Laupacis A, Keown P A, Ulan R A, McKenzie N, Stiller C R
Can Med Assoc J. 1982 May 1;126(9):1041-6.
Cyclosporin A (CyA) is a powerful immunosuppressive agent whose lack of myelotoxicity makes it unique among nonsteroidal drugs currently given for immunosuppression. It has been used with initial success in recipients of kidney, liver, bone marrow and pancreas transplants, and it may also have clinical application in the treatment of autoimmune disorders. In regard to its use in transplant recipients, there are many remaining questions about its mechanism of action, the optimum dose, whether it should be used alone or with other immunosuppressants, whether it can suppress chronic rejection and what its long-term side effects may be. These questions can only be answered by further careful laboratory investigation and controlled clinical trials. Until then, CyA should only be administered in centres experienced in its use.
环孢素A(CyA)是一种强效免疫抑制剂,其无骨髓毒性使其在目前用于免疫抑制的非甾体类药物中独具特色。它已在肾、肝、骨髓和胰腺移植受者中初步成功应用,并且在自身免疫性疾病的治疗中可能也有临床应用价值。关于其在移植受者中的应用,在其作用机制、最佳剂量、是否应单独使用或与其他免疫抑制剂联合使用、能否抑制慢性排斥反应以及其长期副作用可能有哪些等方面仍存在许多问题。这些问题只能通过进一步仔细的实验室研究和对照临床试验来回答。在此之前,环孢素A应仅在有使用经验的中心给药。